Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The General & Plastic Surgery Devices market in Czechia is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, and favorable local circumstances. Customer preferences in Czechia are driving the growth of the General & Plastic Surgery Devices market. There is a growing demand for cosmetic procedures among the population, driven by factors such as increasing disposable income, changing beauty standards, and a desire to enhance one's appearance. Czechia has become a popular destination for medical tourism, attracting patients from neighboring countries who seek affordable and high-quality cosmetic procedures. This influx of patients has contributed to the growth of the General & Plastic Surgery Devices market in the country. Trends in the market indicate a shift towards minimally invasive procedures and non-surgical treatments. Patients are increasingly opting for procedures that require less downtime and offer quicker recovery. This trend is driven by advancements in technology, which have led to the development of innovative devices and techniques that allow for less invasive procedures. In addition, there is a growing awareness of the risks associated with traditional surgical procedures, leading patients to seek safer alternatives. The demand for devices such as lasers, injectables, and non-surgical body contouring devices is on the rise in Czechia. Local special circumstances also contribute to the growth of the General & Plastic Surgery Devices market in Czechia. The country has a well-developed healthcare system with a high level of expertise in the field of plastic surgery. Czechia is known for its skilled surgeons and state-of-the-art medical facilities, attracting both local and international patients. Furthermore, the cost of cosmetic procedures in Czechia is relatively lower compared to other European countries, making it an attractive destination for patients seeking affordable treatments. Underlying macroeconomic factors also play a role in the development of the General & Plastic Surgery Devices market in Czechia. The country's stable economy and increasing disposable income levels have contributed to the growing demand for cosmetic procedures. As the economy continues to grow, more individuals have the financial means to invest in their appearance and undergo cosmetic treatments. Additionally, the aging population in Czechia is driving the demand for anti-aging procedures and treatments, further boosting the General & Plastic Surgery Devices market. In conclusion, the General & Plastic Surgery Devices market in Czechia is experiencing growth due to customer preferences, trends towards minimally invasive procedures, favorable local circumstances, and underlying macroeconomic factors. The market is expected to continue expanding as the demand for cosmetic procedures and advancements in technology continue to drive the industry forward.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights